Towa Pharmaceutical Co., Ltd. (TWAPF)

Market Cap	999.40M
Revenue (ttm)	1.73B
Net Income (ttm)	126.79M
Shares Out	n/a
EPS (ttm)	2.58
PE Ratio	7.88
Forward PE	n/a
Dividend	0.48 (1.88%)
Ex-Dividend Date	Mar 28, 2025

Volume	200
Average Volume	162
Open	25.33
Previous Close	16.83
Day's Range	25.33 - 25.33
52-Week Range	16.83 - 25.33
Beta	-0.20
RSI	n/a
Earnings Date	Aug 7, 2025

About Towa Pharmaceutical

Towa Pharmaceutical Co., Ltd., together with its subsidiaries, researches, develops, produces, and sells ethical drugs, active pharmaceutical ingredients, and intermediates in Japan. The company provides its products in the therapeutic areas of digestive system, nervous system, and allergic diseases, as well as vitamins, antibiotics, and oncology products. It also offers IT service related to healthcare; and disease risk testing services. In addition, the company is involved with research and development of diagnostic drugs; and planning, devel...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1951
• Employees: 4,588
• Stock Exchange: OTCMKTS
• Ticker Symbol: TWAPF

Financial Performance

In 2024, Towa Pharmaceutical's revenue was 259.59 billion, an increase of 13.89% compared to the previous year's 227.93 billion. Earnings were 18.99 billion, an increase of 17.39%.

Financial numbers in JPY